Subscribe to our Newsletter
Prof. Würstlein presents real-world clinical cases highlighting the management of early HR+ HER2- breast cancer patients at high risk of recurrence. The session emphasizes practical decision-making, treatment sequencing, and optimizing outcomes through evidence-based approaches.
